SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:kth-284778"
 

Sökning: onr:"swepub:oai:DiVA.org:kth-284778" > Blood-derived bioma...

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy

Strandberg, Kristin (författare)
KTH,Proteinvetenskap,KTH Royal Inst Technol, Sch Chem Biotechnol & Hlth, Dept Prot Sci, Stockholm, Sweden.
Ayoglu, Burcu (författare)
KTH,Proteinvetenskap,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Dept Prot Sci, SciLifeLab, Stockholm, Sweden.
Roos, A. (författare)
Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.;Leibniz Inst Analyt Wissensch ISAS, Dortmund, Germany.
visa fler...
Reza, M. (författare)
Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
Niks, E. (författare)
Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands.
Signorelli, M. (författare)
Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands.
Fasterius, Erik, 1987- (författare)
KTH,Proteinvetenskap,KTH Royal Inst Technol, Sch Chem Biotechnol & Hlth, Dept Prot Sci, Stockholm, Sweden.
Pontén, Fredrik (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Klinisk och experimentell patologi
Lochmüller, H. (författare)
Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.;Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.;Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat, Ctr Nacl Anal Gen CNAGCRG, Barcelona, Spain.
Domingos, J. (författare)
UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.;Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.
Ala, P. (författare)
UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
Muntoni, F. (författare)
UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.;UCL, Great Ormond St Inst Child Hlth, Natl Inst Hlth Res, London WC1N 1EH, England.
Aartsma-Rus, A. (författare)
Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.;Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.
Spitali, P. (författare)
Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.
Nilsson, Peter (författare)
KTH,Proteinvetenskap,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Dept Prot Sci, SciLifeLab, Stockholm, Sweden.
Al-Khalili Szigyarto, Cristina (författare)
KTH,Proteinvetenskap,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Sch Chem Biotechnol & Hlth, Dept Prot Sci, Stockholm, Sweden.;KTH Royal Inst Technol, Dept Prot Sci, SciLifeLab, Stockholm, Sweden.
visa färre...
 (creator_code:org_t)
IOS Press, 2020
2020
Engelska.
Ingår i: Journal of Neuromuscular Diseases. - : IOS Press. - 2214-3599 .- 2214-3602. ; 7:3, s. 231-246
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Duchenne Muscular Dystrophy is a severe, incurable disorder caused by mutations in the dystrophin gene. The disease is characterized by decreased muscle function, impaired muscle regeneration and increased inflammation. In a clinical context, muscle deterioration, is evaluated using physical tests and analysis of muscle biopsies, which fail to accurately monitor the disease progression. Objectives: This study aims to confirm and asses the value of blood protein biomarkers as disease progression markers using one of the largest longitudinal collection of samples. Methods: A total of 560 samples, both serum and plasma, collected at three clinical sites are analyzed using a suspension bead array platform to assess 118 proteins targeted by 250 antibodies in microliter amount of samples. Results: Nine proteins are confirmed as disease progression biomarkers in both plasma and serum. Abundance of these biomarkers decreases as the disease progresses but follows different trajectories. While carbonic anhydrase 3, microtubule associated protein 4 and collagen type I alpha 1 chain decline rather constantly over time, myosin light chain 3, electron transfer flavoprotein A, troponin T, malate dehydrogenase 2, lactate dehydrogenase B and nestin plateaus in early teens. Electron transfer flavoprotein A, correlates with the outcome of 6-minutes-walking-test whereas malate dehydrogenase 2 together with myosin light chain 3, carbonic anhydrase 3 and nestin correlate with respiratory capacity. Conclusions: Nine biomarkers have been identified that correlate with disease milestones, functional tests and respiratory capacity. Together these biomarkers recapitulate different stages of the disorder that, if validated can improve disease progression monitoring.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)

Nyckelord

Affinity-based proteomics
disease progression
Duchenne muscular dystrophy
protein biomarkers
serum and plasma
carbonate dehydratase III
collagen type 1
dystrophin
electron transferring flavoprotein
electron transferring flavoprotein A
lactate dehydrogenase
lactate dehydrogenase B
malate dehydrogenase
malate dehydrogenase 2
microtubule associated protein 4
myosin light chain
myosin light chain 3
nestin
troponin T
unclassified drug
adolescent
adult
aged
Article
blood sampling
breathing
child
controlled study
correlation analysis
disease course
female
gene mutation
human
immunohistochemistry
longitudinal study
major clinical study
male
middle aged
mobilization
preschool child
priority journal
protein analysis
protein expression
protein microarray
school child
six minute walk test
Western blotting
young adult

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy